• Roh ullah
  • AK Khursheed
  • GM Burdey
  • SRH Hamdani
  • Javaid Javaid
  • S Kamran
  • J Nusrat


Background: A retrospective study of 659 patients of Ca Esophagus was conducted from 1 January 1990 to 31s'December 1999 (10 years) at CENAR Quetta. The aim of this study was to highlight the incidence, early detection,management, and various other parameters of Ca Esophagus. Results: During this period, 5819 new eases of cancerwere registered. Cases of Ca Esophagus constituted 659 (11.32 %) in number. It was studied that this cancer was the3th most common cancer registered in both sexes at our centre. 65 new cases of Ca Esophagus were registered atCENAR Quetta per annum on an average. Males slightly dominated the females. Maximum number of cases 470(71.31 %). were reported between ages 4 1 - 6 0 years with a median age of 55 years. Maximum number of cases399 (60.57 %), involved lower 3' of Esophagus. Squamous cell carcinoma was the most common histopathology seenin 574 cases (87.10 %). These patients were mainly treated with radiation therapy, palliative, because by the time theyreported, they were found in stage 111 and beyond. Some patients were also treated with chemotherapy along withradiation, but the overall prognosis was poor. A few patients have also undergone palliative surgery; such as pullthrough or push through tubes prior to radiotherapy. Conclusions: Since the patients presented with late & advanceddisease, it is, therefore, recommended that all cases of dysphagia particularly from this region of the country shouldbe thoroughly investigated with the suspicion of Ca Esophagus. It is further suggested that general population beeducated about the potential risk factors like smoking, use of naswar, beetle nut chewing, and intake of very hot food& beverages


I Fink U. Stein 10, Wilke H, Roder JD. Siewert JR,

Multimodal treatment for squamous cell Esophageal cancer.

World J Surg 1995. 19: 198-204

Flood WA and Forastiere AA. Esophageal cancer. Current

Opinion in Oncology 1995. 7: 381-386.

Kelson DP, llson DH Chemotherapy and combined modality

therapy lor Esophageal cancer Chest 1995, 107 S224-S232

Blot WJ. Esophageal cancer trends and risk factors. Seminars

in Oncol 1994; 21:403-410.

Blot WJ. Dcvcsa SS. KneHer RW. Eraumeni JF jr. Rising

incidence of adenocarcinoma of the Esophagus and gastric

cardia, JAMA 1991;265:1287-1289.

Blot WJ, Li JY, Taylor PR ct al. Nutrition intervention trials

in Linxian, China: Supplementation with specific vitamin/

mineral combinations, cancer incidence, and disease-specific

mortality in the general population. J Natl Cancer Inst 1993;


Brown LM. Hoover RN, Greenberg RS. Schoenberg JB,

Schwartz AG. Swanson JM. Are racial differences in

squamous cell Esophageal cancer explained by alcohol and

tobacco use? J Natl Cancer Inst 1994; 86:1340-1345.

Brown LM. Swanson CA. Gridley G, Swanson GM.

Schoenberg JB, Greenberg RS et al. Adenocarcinoma of the

Esophagus: role of obesity and diet. J Natl Cancer Inst 1995.


Cheng KK, Day NE. Davies TW. Oesophageal cancer

mortality in Europe: paradoxical time trend in relation to

smoking and drinking. Br J Cancer 1992, 65: 613-617.

Day NE. Varghese C. Oesophageal cancer. Cancer Surv 1994:


Falk GW. Richter JE. Reflux disease and Barrett's Esophagus

Endoscopy 1996; 28:13-21.

Fink U. Stein HJ. Wilke H, Roder JD, Siewert JR. Multimodal

treatment for squamous cell Esophageal cancer World J Surg

; 19: 198-204.

Flood WA. Forestier AA Esophageal cancer. Current Opinion

in Oncology 1995,7: 381-386.

Froelicher P. Miller G, The European experience with

Esophageal cancer limited to the mucosa and submucosa.

Gastrointestinal Endoscopy 1986;32:88-90.

Gray JR. Coldman AJ. Mac Donald WC. Cigarette and alcohol

use in patients with adenocarcinoma of the gastric cardia or

lower Esophagus. Cancer 1992; 69: 2227-2231

Kelsen DP. llson DH. Chemotherapy and combined modality

therapy for Esophageal cancer. Chest 1995; 107: S224-S232.

17 Lambert R Endoscopic detection and treatment of early

Esophageal cancer: a critical analysis. Endoscopy 1995;27:12-

Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, Ershow AG et

al. Nutrition intervention trials in Linxian, China:

Multiple vitamin/mineral supplementation, cancer incidence

and disease-specific mortality among adults with Esophageal

dysplasia. J Natl Cancer Inst 1993; 85: 1492-1498

Light dale CJ. Diagnosis of esophagogastric tumors.

Endoscopy 1996; 28: 22-26

Macfarlane GJ, Plesko I, Kramarova E et al. Epidemiological

features of gastric and oesophageal cancer in Slovakia. Br J

Cancer 1994; 70: 177-9.

Moller FI. Boyle P, Maisonneuve P. La Vecchia C, Jensen OM

et al. Changing mortality from Esophageal cancer in males in

Denmark and other European countries in relation to changing

levels of alcohol consumption.

Cancer Causes Control 1990; 1:181-188.

Spechler S. Barrett's Esophagus Sem Oncol 1994; 21:


Akiyama H. Tsurumaru M. Udagawa H, Kajiyama Y.

Radical lymph node dissection for cancer of the thoracic

Esophagus, Ann Surg 1994; 220: 364-377